Weill Cornell Medicine Team Creates Self-Renewing Hematopoietic Stem Cells for Transplantation

Hematopoietic stem cells (HSCs) are long-lasting cells that mature into all types of blood cells: white blood cells, red blood cells and platelets. Almost a trillion new blood cells must be replaced each day to replace normal loss of old blood cells. “Bone Marrow Transplant” is a procedure currently used by clinicians to transplant HSCs and cure a wide range of blood diseases. But not all patients have a suitable donor for a HSC transplant. For the first-time ever, Dr. Joseph Scandura, Scientific Director of the Silver MPN Center, and collaborators across Weill Cornell Medicine have discovered an innovative method to generate these blood-forming stem cells. Learn more about the implications for stem cell transplantation and curing patients with genetic and acquired blood diseases including MPNs.

Richard T. Silver MD Myeloproliferative Neoplasms Center 525 East 70th St., Starr Pavillion, 3rd Floor New York, NY 10021 SilverMPNCenter@med.cornell.edu